TrialCirculation2024

Mineralocorticoid Receptor Antagonism Prevents Aortic Plaque Progression and Reduces Left Ventricular Mass and Fibrosis in Patients With Type 2 Diabetes and Chronic Kidney Disease: The MAGMA Trial.

Sanjay Rajagopalan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.